American CryoStem Corporation
CRYO · OTC
6/30/2022 | 3/31/2022 | 12/31/2021 | 9/30/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | -$0 |
| % Growth | 33.4% | -47.8% | 116.9% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | -$0 |
| % Margin | 88.8% | 90.6% | 69.2% | 101.4% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $1 | $0 | $1 |
| SG&A Expenses | $0 | $1 | $0 | $1 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | -$0 |
| Operating Expenses | $0 | $1 | $0 | $1 |
| Operating Income | -$0 | -$1 | -$0 | -$2 |
| % Margin | -884.6% | -2,938.6% | -579.4% | 546.5% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | -$0 |
| Pre-Tax Income | -$0 | -$1 | -$0 | -$2 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$0 | -$1 | -$0 | -$2 |
| % Margin | -943% | -3,018% | -622.3% | 568.5% |
| EPS | -0.009 | -0.022 | -0.007 | -0.034 |
| % Growth | 59.1% | -214.3% | 79.5% | – |
| EPS Diluted | -0.009 | -0.022 | -0.007 | -0.034 |
| Weighted Avg Shares Out | 44 | 44 | 54 | 60 |
| Weighted Avg Shares Out Dil | 44 | 44 | 54 | 60 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$0 | -$1 | -$0 | -$2 |
| % Margin | -834.7% | -2,852.2% | -555.6% | 558.4% |